Building Research for Intervention Development in Gliosis and Eating Habits
University of Washington · with National Heart, Lung, and Blood Institute (NHLBI) · NCT06870578
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 9+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 75
- US sites recruiting
- 1
- Study start
- April 3, 2025
- Record last updated
- June 6, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to 1) use magnetic resonance imaging (MRI) to evaluate the effect of nutritious foods on inflammation in the human hypothalamus of children and 2) assess the feasibility and acceptability of nutritious food feeding intervention strategies in children with overweight or obesity.
Being studied: Diet modification
Conditions: Gliosis; Child Obesity; Eating
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Study1: Adult caregiver and Child age 9-11y. Willing to come to in-person focus group
- Study 2: Age 9-11y, BMI ≥85th and ≤95th percentile for age and sex
- Study 3:Adult caregiver with child who qualify for free or reduced-cost lunch in WA State. Child age 9-11y and with overweight.
Exclusion Criteria (study 1 child participants and study 3 criteria for children of adult participants):
- Significant health conditions including type 2 diabetes
- History of major weight loss or eating disorder
- Current use of medications known to alter appetite or body weight (e.g., stimulants for ADHD)
- Documented cognitive disorder
- Severe food allergies, vegetarian, or vegan (Study 1 only)
- Unable to make the session date
Exclusion Criteria (study 2, child participants):
- Significant health conditions including type 2 diabetes
- History of major weight loss or eating disorder
- Current use of medications known to alter appetite or body weight (e.g., stimulants for ADHD)
- Documented cognitive disorder
- MRI contraindication (e.g., braces, claustrophobia)
- Weight >330 pounds (MRI limit)
- Severe food allergies, vegetarian, or vegan
- Currently in formal weight loss program
Recruiting US locations
University of Washington
Seattle, WA 98109
Site contact: BRIDGE Study · 206-616-6360 · bridge-study@uw.edu
Study contacts (from the official record)
- BRIDGE Study · 206 616-6360 · bridge-study@uw.edu
Similar studies in Washington
All weight loss studies in Washington →- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Renton, WA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Redmond, WA + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie
- Location
- Renton, WA + 58 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Seattle, WA + 13 other US sites
- Eligibility basics
- Ages 10–18